Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea · Delayed Price · Currency is KRW 5,670.00
-80.00 (-1.39%)
At close: Oct 23, 2026
Wonbiogen Market Cap
Wonbiogen has a market cap or net worth of 38.59 billion as of October 23, 2026. It is the 34,106th most valuable company in the world and the 1,979th biggest in South Korea. Its market cap has increased by 3.82% in one year.
Market Cap
38.59B
Enterprise Value
31.89B
Revenue
37.80B
Global Rank
Country Rank
#1,979 South Korea
PE Ratio
4.70
ChartMarket Cap Chart
Since January 26, 2021, Wonbiogen's market cap has decreased from 47.59B to 38.59B, a decrease of -18.92%. That is a compound annual growth rate of -3.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 38.59B | -18.56% |
| Dec 30, 2025 | 47.38B | 16.35% |
| Dec 30, 2024 | 40.72B | -32.55% |
| Dec 28, 2023 | 60.37B | 3.39% |
| Dec 29, 2022 | 58.40B | -21.09% |
| Dec 30, 2021 | 74.00B | 55.49% |
| Jan 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DuChemBIO | 238.94B |
| JW Shinyak | 132.14B |
| Sewoon Medical | 97.85B |
| CG MedTech | 96.65B |
| OSTEONIC | 83.25B |
| SCL Science | 78.23B |
| MEDYSSEY Co.,Ltd | 41.74B |
| KM Corporation | 41.49B |